A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer

NCT01196247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Previously Treated Metastatic Pancreatic Cancer

Interventions

DRUG: Drug will be recommended based on IHC/Fish, CGH and Pan-XenoBank

Sponsor

Translational Drug Development

Collaborators

[object Object]
[object Object]
[object Object]